BRCA Reversion Mutations in Circulating Tumor DNA Predict Primary and Acquired Resistance to the PARP Inhibitor Rucaparib in High-Grade Ovarian Carcinoma
Lin, Kevin K, Harrell, Maria I., Oza, Amit M, Oaknin, Ana, Ray-Coquard, Isabelle, Tinker, Anna V., Helman, Elena, Radke, Marc R., Say, Carmen, Vo, Lan-Thanh, Mann, Elaina, Isaacson, Jeffrey D, MaloneyLanguage:
english
Journal:
Cancer Discovery
DOI:
10.1158/2159-8290.CD-18-0715
Date:
November, 2018
File:
PDF, 693 KB
english, 2018